Bharat Biotech
-
Top News
Covaxin Approved For Phase II-III Trials In 2-18 Years Age Group, Says Niti Aayog Member
Mumbai: NITI Aayog member (health) Dr VK Paul said on Tuesday that Bharat Biotech is set to begin the second…
Read More » -
Top News
Covaxin Phase II/III Clinical Trial For 2-18 Age Group Cleared By DCGI
Mumbai: The Drugs Controller General of India (DCGI) has approved Phase II/III clinical trial of Covaxin in the age group…
Read More » -
INDIA
Bharat Biotech Refused To Supply Covaxin To Delhi On Centre’s Orders: Sisodia
Mumbai: Delhi Deputy Chief Minister Manish Sisodia on Wednesday said that the vaccine suppliers have said that they can’t provide…
Read More » -
Top News
Bombay HC Allows Use Of Idle Plant In Pune To Manufacture Covaxin
Mumbai: Bombay High Court has allowed Biovet Private Limited, an associate firm of the Bharat Biotech, to take over the…
Read More » -
Top News
Bharat Biotech’s Covaxin Gets Nod For Phase 2/3 Trials On 2-18-Yr-Olds: Report
Mumbai: The Central Drugs Standard Control Organisation’s (CDSCO) Subject Expert Committee has reportedly given its nod to Bharat Biotech’s Covaxin…
Read More » -
Top News
No Need For Court To Interfere: Govt To Supreme Court On Vaccine Policy
Mumbai: After being asked to rethink its vaccine policy, the Centre on Sunday told the Supreme Court that its vaccination…
Read More » -
Top News
Maharashtra Needs 12 Cr COVID-19 Vaccines For Phase 3: Rajesh Tope
Mumbai: The Maharashtra government has written to COVID-19 vaccine manufacturers Serum Institute of India (SII) and Bharat Biotech about the…
Read More » -
Top News
Bharat Biotech’s Covaxin Found 100% Effective Against ‘Severe Covid Disease’ In Phase-3 Interim Analysis
Mumbai: Bharat Biotech and ICMR have announced interim results from phase 3 trials of Covaxin that demonstrate overall interim clinical…
Read More » -
INDIA
India Likely To Have 200 Million Vaccines By June: Reports
Mumbai: The supply of jabs is expected to increase from June, Vaccine manufacturers in India are planning to ramp up…
Read More » -
Top News
Bharat Biotech To Get ₹65 Cr From Govt To Boost Covaxin Production
Mumbai: The government has announced financial assistance worth ₹65 crores to Bharat Biotech to ramp up manufacturing of its COVID-19…
Read More »